MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear Clusters.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
10 2022
Historique:
received: 25 01 2022
accepted: 28 06 2022
pubmed: 23 9 2022
medline: 30 12 2022
entrez: 22 9 2022
Statut: ppublish

Résumé

Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC) is a new, molecularly defined glioneuronal CNS tumor type. The objective of the present study was to describe MR imaging and clinical characteristics of patients with DGONC. Preoperative MR images of 9 patients with DGONC (median age at diagnosis, 9.9 years; range, 4.2-21.8 years) were reviewed. All tumors were located superficially in the frontal/temporal lobes and sharply delineated, displaying little mass effect. Near the circle of Willis, the tumors encompassed the arteries. All except one demonstrated characteristics of low-to-intermediate aggressiveness with high-to-intermediate T2WI and ADC signals and bone remodeling. Most tumors ( This case series presents radiomorphologic characteristics highly predictive of DGONC that contrast with the typical aspects of the original histopathologic diagnoses. This presentation underlines the definition of DGONC as a separate entity, from a clinical perspective. Complete resection may be favorable for long-term disease control in patients with DGONC. The efficacy of nonsurgical treatment modalities should be evaluated in larger series.

Sections du résumé

BACKGROUND AND PURPOSE
Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC) is a new, molecularly defined glioneuronal CNS tumor type. The objective of the present study was to describe MR imaging and clinical characteristics of patients with DGONC.
MATERIALS AND METHODS
Preoperative MR images of 9 patients with DGONC (median age at diagnosis, 9.9 years; range, 4.2-21.8 years) were reviewed.
RESULTS
All tumors were located superficially in the frontal/temporal lobes and sharply delineated, displaying little mass effect. Near the circle of Willis, the tumors encompassed the arteries. All except one demonstrated characteristics of low-to-intermediate aggressiveness with high-to-intermediate T2WI and ADC signals and bone remodeling. Most tumors (
CONCLUSIONS
This case series presents radiomorphologic characteristics highly predictive of DGONC that contrast with the typical aspects of the original histopathologic diagnoses. This presentation underlines the definition of DGONC as a separate entity, from a clinical perspective. Complete resection may be favorable for long-term disease control in patients with DGONC. The efficacy of nonsurgical treatment modalities should be evaluated in larger series.

Identifiants

pubmed: 36137663
pii: ajnr.A7647
doi: 10.3174/ajnr.A7647
pmc: PMC9575520
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1523-1529

Informations de copyright

© 2022 by American Journal of Neuroradiology.

Auteurs

M Benesch (M)

From the Division of Pediatric Hematology and Oncology (M.B., T.P.), Department of Pediatrics and Adolescent Medicine.

T Perwein (T)

From the Division of Pediatric Hematology and Oncology (M.B., T.P.), Department of Pediatrics and Adolescent Medicine thomas.perwein@medunigraz.at.

G Apfaltrer (G)

Division of Pediatric Radiology (G.A.), Department of Radiology, Medical University Graz, Graz, Austria.

T Langer (T)

Departments of Pediatrics (T.L.).

A Neumann (A)

Neuroradiology (A.N.), University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.

I B Brecht (IB)

Pediatric Hematology and Oncology (I.B.B.), Children's Hospital.

M U Schuhmann (MU)

Division of Pediatric Neurosurgery (M.U.S.), Department of Neurosurgery, Eberhard-Karls University Tübingen, Tübingen, Germany.

H Cario (H)

Department of Pediatrics and Adolescent Medicine (H.C.), Ulm University Medical Center, Ulm, Germany.

M C Frühwald (MC)

Swabian Children's Cancer Center (M.C.F.).

K Vollert (K)

Pediatric and Adolescent Medicine and Departments of Diagnostic and Interventional Radiology and Neuroradiology (K.V., B.B.), University Medical Center Augsburg, Augsburg, Germany.

M van Buiren (M)

Department of Pediatric Hematology and Oncology (M.v.B.), Center for Pediatrics, Medical Center-University of Freiburg, Freiburg, Germany.

M Y Deng (MY)

Hopp Children's Cancer Center Heidelberg (M.Y.D., F.S.).

A Seitz (A)

German Cancer Research Center and Department of Neuroradiology (A.S.).

C Haberler (C)

Division of Neuropathology and Neurochemistry (C.H.), Department of Neurology, Medical University of Vienna, Vienna, Austria.

M Mynarek (M)

Department of Pediatric Hematology and Oncology (M.M.).
Mildred Scheel Cancer Career Center (M.M.), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

C Kramm (C)

Division of Pediatric Hematology and Oncology (C.K.), University Medical Center Göttingen, Göttingen, Germany.

F Sahm (F)

Hopp Children's Cancer Center Heidelberg (M.Y.D., F.S.).
Department of Neuropathology (F.S.), Institute of Pathology.
Clinical Cooperation Unit Neuropathology (F.S.), German Cancer Consortium, German Cancer Research Center, Heidelberg University Hospital, Heidelberg, Germany.

P A Robe (PA)

Department of Neurology and Neurosurgery (P.A.R.).

J W Dankbaar (JW)

Department of Radiology (J.W.D.), University Medical Center Utrecht, Utrecht, the Netherlands.

K V Hoff (KV)

Department of Pediatric Oncology and Hematology (K.V.H.), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

M Warmuth-Metz (M)

Institute of Diagnostic and Interventional Neuroradiology (M.W.-M.), University Hospital Würzburg, Würzburg, Germany.

B Bison (B)

Pediatric and Adolescent Medicine and Departments of Diagnostic and Interventional Radiology and Neuroradiology (K.V., B.B.), University Medical Center Augsburg, Augsburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH